I would expect to see some results about this trial by around this time, but I haven't seen or heard anything through the usual academic channels. However, these results often trickle in through the financial news, sad to say. I've tried Google, the company's website, and twitter, and I'm not finding any recent news. Perhaps they're referring to the START trial with Stimuvax (see http://cancergrace.org/lung/2013/01/09/start-trial-fails/), which was just recently reported as negative for a survival benefit -- or else it's just a rumor that might be substantiated in upcoming news.
Obviously, we still need to learn things from official channels, but it's quite a development that lung cancer specialists are learning news about lung cancer treatments from patient group sides. I'd like some validating information, but it sounds like the chatter is right and that we'll probably get an official declaration of futility in 4 days. I suspect that the average patient on Inspire or GRACE knows more about ROS1 than their oncologist, and this is another example of patients knowing more than almost any doctor because the crowdsourcing of information.
Thanks for the tip, CS, disappointing though it is.
Reply # - January 26, 2013, 04:05 PM
Reply To: Lucanix
I would expect to see some results about this trial by around this time, but I haven't seen or heard anything through the usual academic channels. However, these results often trickle in through the financial news, sad to say. I've tried Google, the company's website, and twitter, and I'm not finding any recent news. Perhaps they're referring to the START trial with Stimuvax (see http://cancergrace.org/lung/2013/01/09/start-trial-fails/), which was just recently reported as negative for a survival benefit -- or else it's just a rumor that might be substantiated in upcoming news.
-Dr. West
Reply # - January 27, 2013, 08:46 AM
Reply To: Lucanix
I suspect it emanates from this discussion on Inspire, which in turn was prompted by a patient's email from his or her oncologist at UCLA:
http://www.inspire.com/groups/lung-cancer-survivors/discussion/lucanix-…
Reply # - January 27, 2013, 10:27 AM
Reply To: Lucanix
Obviously, we still need to learn things from official channels, but it's quite a development that lung cancer specialists are learning news about lung cancer treatments from patient group sides. I'd like some validating information, but it sounds like the chatter is right and that we'll probably get an official declaration of futility in 4 days. I suspect that the average patient on Inspire or GRACE knows more about ROS1 than their oncologist, and this is another example of patients knowing more than almost any doctor because the crowdsourcing of information.
Thanks for the tip, CS, disappointing though it is.
-Dr. West